Efficacy of Apremilast in Patients with Moderate-to-Severe Genital Psoriasis: Body Surface Area Subgroup Results from the Phase 3 DISCREET Trial. J of Skin [Internet]. 2023 Nov. 13 [cited 2025 Jun. 25];7(6):s255. Available from: https://skin.dermsquared.com/skin/article/view/2443